Bessemer Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-97
| Closed | -$3K | – | 2202 |
|
|
2022
Q4 | $3K | Hold |
97
| – | – | ﹤0.01% | 1746 |
|
|
2022
Q3 | $3K | Buy |
97
+5
| +5% | +$155 | ﹤0.01% | 1884 |
|
|
2022
Q2 | $4K | Hold |
92
| – | – | ﹤0.01% | 1636 |
|
|
2022
Q1 | $5K | Buy |
+92
| New | +$5K | ﹤0.01% | 1550 |
|
|
2020
Q3 | – | Sell |
-30,800
| Closed | -$1.48M | – | 1725 |
|
|
2020
Q2 | $1.48M | Buy |
30,800
+1,300
| +4% | +$62.4K | ﹤0.01% | 586 |
|
|
2020
Q1 | $1.36M | Buy |
29,500
+11,400
| +63% | +$524K | 0.01% | 523 |
|
|
2019
Q4 | $1.09M | Buy |
18,100
+17,000
| +1,545% | +$1.02M | ﹤0.01% | 725 |
|
|
2019
Q3 | $62K | Buy |
+1,100
| New | +$62K | ﹤0.01% | 1235 |
|